Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant

Evelyne Véricel1, Caroline Januel, Martine Carreras

  • 1Unité mixte de Recherche 585 Institut National de la Santé et de la Recherche Médicale/Institut National des Sciences Appliquées de Lyon, Institute for Multidisciplinary Biochemistry of Lipids, Villeurbanne, France. evelyn.vericel@insa-lyon.fr

Diabetes
|March 30, 2004
PubMed

Insights

Diabetic patients show increased platelet activation and oxidative stress, even without vascular complications. These findings highlight early platelet dysfunction in diabetes, contributing to vascular disease risk.

Area of Science:

  • Biochemistry
  • Hematology
  • Endocrinology

Background:

  • Vascular complications are a major cause of death in diabetic patients.
  • Platelet contribution to thrombosis is known, but their role in atherosclerosis initiation is emerging.
  • Diabetic platelet dysfunction may precede clinical vascular complications.

Purpose of the Study:

  • To investigate basal arachidonic acid metabolism and platelet redox status in type 1 and type 2 diabetes.
  • To compare these parameters in diabetic patients without vascular complications versus healthy controls.
  • To understand early platelet alterations contributing to diabetic vascular disease risk.

Main Methods:

  • Analysis of thromboxane B(2) and malondialdehyde levels in resting platelets.
  • Measurement of platelet vitamin E levels and glutathione peroxidase activity.
  • Comparison between diabetic patients (type 1 and type 2) and control groups.

Main Results:

  • Significantly increased thromboxane B(2) in platelets from both type 1 (58%) and type 2 (88%) diabetic patients.
  • Elevated platelet malondialdehyde in type 2 diabetes (67%).
  • Reduced vitamin E levels and glutathione peroxidase activity in platelets from diabetic patients.

Conclusions:

  • Platelet hyperactivation is present in well-controlled diabetic patients without complications.
  • Increased oxidative stress and impaired antioxidant defenses are observed, particularly in type 2 diabetes.
  • These platelet abnormalities contribute to the elevated vascular disease risk in diabetes.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...